openPR Logo
Press release

North America Topical Drug Delivery Market Worth USD 89.3 Billion by 2017-2024

11-06-2017 09:18 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

North America Topical Drug Delivery Market – Trends and Forecast to 2024

North America Topical Drug Delivery Market – Trends and Forecast to 2024

The new report “North America Topical Drug Delivery Market, By Product Type {Topical Drug Delivery Formulations (Solid, Liquid, Semi-Solid), Transdermal Drug Delivery Devices (Patches, Gels)}, End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), Distribution Channel (Direct Tenders, Retail), Country (U.S, Canada, Mexico)” – Trends and Forecast to 2024

North America Topical Drug Delivery Market is expected to reach USD 89.3 billion by 2024 from USD 48.0 billion in 2016, growing at a CAGR of 8.0% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-topical-drug-delivery-market

Some of the major companies operating in this market are:

• MedPharm
• Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services Inc A J&J Company)
• Crescita Therapeutics
• Galderma S.A.
• Biofarmitalia s.r.l
• Pharmatek Laboratories, Inc.
• Stiefel Laboratories, Inc.
• Tapemark
• Acrux Limited
• Nitto Denko Corporation
• Valeant Pharmaceuticals International, Inc.
• Skinvisible Pharmaceuticals, Inc.
• Mylan Pharmaceuticals Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Pocono Coated Products LLC
• TheraSolve NV.
• Samyang Biopharmaceuticals Corporation
• Lohmann Therapie-Systeme AG
• Prosollus Pharmaceuticals
• Easton Pharmaceuticals Inc.
• Novosis AG
• Antares Pharma, Inc.
• Endo Pharmaceuticals Inc.
• Transdermal Technologies, Inc.
• Sheffield Pharmaceuticals, Inc.
• Solvay
• 3M Drug Delivery Systems.

The North America topical drug delivery market is segmented on the basis of product type, distribution channel, end user, and geography.

On the basis of product typethe North America Topical Drug Delivery Market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid, and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels, and pastes. The solid drugs segment is further segmented into powders and suppositors. The liquid drugs segment is further classified into solutions and suspensions.

On the basis of end users, the North America Topical Drug Delivery Market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.

Based on country, the North America Topical Drug Delivery Market is segmented into U.S, Canada, and Mexico.

The North America topical drug delivery market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Inquiry before Buying about this Market Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=north-america-topical-drug-delivery-market

Table of Contents:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.7. TAPEMARK
11.8. NITTO DENKO CORPORATION
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9. MYLAN PHARMACEUTICALS INC.
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.10. THERASOLVE NV.
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.12. LOHMANN THERAPIE-SYSTEME AG
11.13. PROSOLLUS PHARMACEUTICALS
11.14. EASTON PHARMACEUTICALS INC.
11.15. ANTARES PHARMA, INC.
11.16. ENDO PHARMACEUTICALS INC.
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.19. SOLVAY
11.20. 3M DRUG DELIVERY SYSTEMS

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/north-america-topical-drug-delivery-market/

Related Report

Asia-Pacific (APAC) Infusion Pumps Market – Industry Trends and Forecast to 2024

Asia-Pacific (APAC) Infusion Pumps Market, By Product Types, By End-Users, By Distribution Channel, By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, Rest of APAC) – Indutry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/asia-pacific-infusion-pumps-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Topical Drug Delivery Market Worth USD 89.3 Billion by 2017-2024 here

News-ID: 802541 • Views: 159

More Releases from Data Bridge Market Research

Global Data Center Outsourcing Market Comprehensive Analysis 2019: Key Players a …
This data center outsourcing market report is the most suitable solution for your business requirements in many ways. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s Five Forces analysis. Nowadays, businesses are highly relying on the different segments covered in the market research report which presents better insights to drive the business into right direction. This research study helps the customer understand
Ankylosing Spondylitis (AS) Market – Reliance Life Sciences., Xian Janssen Pha …
Achieving maximum return on investment (ROI) is one of the most aspiring goals for any industry which can be achieved with the greatest market research report. Hence, this Ankylosing Spondylitis Market report deals with the market research of the Medical Devices industry by considering several parameters that are affecting the business growth. This report gives information about the brand awareness, market landscape, possible future issues, industry trends and customer behavior
C-reactive Protein Market – Abaxis, Abbott., Beckman Coulter, F. Hoffmann-La R …
C-reactive Protein Market report is a defined study of the ABC industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. The global C-reactive Protein Market report contains all the company profiles of the major players and brands. The market drivers and restraints have also been explained using SWOT analysis. The report exhibits important product developments and tracks recent acquisitions, mergers and research in the
Blind Spot Solutions Market – Robert Bosch GmbH; Continental AG; DENSO CORPORA …
Global Blind Spot Solutions Market is expected to rise to an estimated value of USD 25.92 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rising incidences of accidents caused with heavy commercial vehicles due to their inability to view the vehicle’s blind spots along with increasing utilization of these systems in premium vehicles. Market Definition: Global

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning